146 related articles for article (PubMed ID: 21226857)
1. Illuminating progression: tracking melanoma metastasis in a gene therapy setting.
Day CP; Merlino G
Pigment Cell Melanoma Res; 2011 Apr; 24(2):260-1. PubMed ID: 21226857
[No Abstract] [Full Text] [Related]
2. [After excision of primary stage I cutaneous melanoma, is an initial evaluation necessary?].
Richard-Lallemand MA
Ann Dermatol Venereol; 1995; 122(5):349-59. PubMed ID: 8572478
[No Abstract] [Full Text] [Related]
3. Prognostic signs in melanoma: state of the art.
Lomuto M; Calabrese P; Giuliani A
J Eur Acad Dermatol Venereol; 2004 May; 18(3):291-300. PubMed ID: 15096138
[TBL] [Abstract][Full Text] [Related]
4. [Current developments concerning malignant skin melanoma].
Dargent M
Maroc Med; 1972 Oct; 52(561):571-86. PubMed ID: 4667467
[No Abstract] [Full Text] [Related]
5. [Prognostic factors and improving treatment of cutaneous melanoma].
Vihinen P; Kähäri VM; Pyrhönen S
Duodecim; 2004; 120(12):1445-56. PubMed ID: 15293705
[No Abstract] [Full Text] [Related]
6. [What are expected improvements in the follow-up and treatment of stage I melanoma?].
Thomas L
Ann Dermatol Venereol; 1995; 122(5):378-88. PubMed ID: 8572482
[No Abstract] [Full Text] [Related]
7. Investigating the metastatic niche in melanoma: a new therapeutic opportunity?
Aladowicz E; Lanfrancone L
Future Oncol; 2014 Apr; 10(5):699-701. PubMed ID: 24799050
[No Abstract] [Full Text] [Related]
8. Melanoma.
Benson C; Gore ME
Cancer Chemother Biol Response Modif; 2001; 19():629-38. PubMed ID: 11686036
[No Abstract] [Full Text] [Related]
9. Metastatic melanoma: Pathologic characterization, current treatment, and complications of therapy.
Wick MR; Gru AA
Semin Diagn Pathol; 2016 Jul; 33(4):204-18. PubMed ID: 27234321
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of the structure of primary melanoma with melanoma metastasis].
Thormann T; Klug H; Günther W; Friedrich C
Dermatol Monatsschr; 1970; 156(5):313-9. PubMed ID: 5509127
[No Abstract] [Full Text] [Related]
11. [Regression of melanoma metastases after immunological therapy].
Malek-Mansour S; Castermans-Elias S; Lapière CM
Dermatologica; 1973; 146(3):156-62. PubMed ID: 4717482
[No Abstract] [Full Text] [Related]
12. New trends in the treatment of malignant melanoma.
Veronesi U; Bajetta E; Cascinelli N; Clemente C; Rilke F
Int Adv Surg Oncol; 1978; 1():113-56. PubMed ID: 399762
[No Abstract] [Full Text] [Related]
13. [Consensus conference. Follow-up of patients surgically treated for stage I melanoma].
Ann Dermatol Venereol; 1995; 122(5):250-8. PubMed ID: 8572461
[No Abstract] [Full Text] [Related]
14. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo.
Onsun N; Büyükbabani N; Ummetoğlu O; Cebeci F
J Dermatol; 2009 Nov; 36(11):612-5. PubMed ID: 19878396
[TBL] [Abstract][Full Text] [Related]
15. [Chromosome studies in metastases of a malignant melanoma in man].
Witkowski R; Zabel R
Dermatol Monatsschr; 1972 Apr; 158(4):255-60. PubMed ID: 5029899
[No Abstract] [Full Text] [Related]
16. [Malignant melanoma. Introduction].
Banzet P
Chirurgie; 1978 Nov; 104(10):946-7. PubMed ID: 747944
[No Abstract] [Full Text] [Related]
17. Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma.
Eberle J; Fecker LF; Hossini AM; Kurbanov BM; Fechner H
Exp Dermatol; 2008 Jan; 17(1):1-11. PubMed ID: 18095940
[TBL] [Abstract][Full Text] [Related]
18. [Gene therapy in malignant melanoma. Interview with D. Schadendorf].
Schadendorf D
Hautarzt; 1996 Dec; 47(12):962-4. PubMed ID: 9081947
[No Abstract] [Full Text] [Related]
19. [Vaccination therapy of melanoma].
Schuler-Thurner B; Schuler G
J Dtsch Dermatol Ges; 2005 Aug; 3(8):630-45. PubMed ID: 16033483
[No Abstract] [Full Text] [Related]
20. [Current aspects in the treatment of malignant melanoma].
Barth A; Cerny T
Schweiz Med Wochenschr; 1994 Sep; 124(36):1592-603. PubMed ID: 7939527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
